Mihaela et al. detailed that knockdown of KRT17 diminished cell motility and invasion capacity and retards tumor growth through p38, AKT/mTOR and ERK/JNK signaling in gastric cancer [12]. This evidence concerns the gene KRT17 and neoplasm.